153 related articles for article (PubMed ID: 35022813)
1. Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture.
Iida H; Sakai Y; Seki T; Watanabe T; Wakao N; Matsui H; Imagama S
Osteoporos Int; 2022 May; 33(5):1147-1154. PubMed ID: 35022813
[TBL] [Abstract][Full Text] [Related]
2. Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study.
Kawabata A; Yoshii T; Hirai T; Ushio S; Kaito T; Yamashita T; Fujiwara H; Nagamoto Y; Matsuoka Y; Suzuki H; Nishimura H; Terai H; Tamai K; Tagami A; Yamada S; Adachi S; Watanabe K; Katsumi K; Ohashi M; Shibuya Y; Harimaya K; Kawaguchi K; Yokoyama N; Oishi H; Doi T; Kimura A; Inoue H; Inoue G; Miyagi M; Saito W; Nakano A; Sakai D; Nukaga T; Ikegami S; Shimizu M; Futatsugi T; Ohtori S; Furuya T; Orita S; Imagama S; Ando K; Kobayashi K; Kiyasu K; Murakami H; Yoshioka K; Seki S; Hongo M; Kakutani K; Yurube T; Aoki Y; Oshima M; Takahata M; Iwata A; Endo H; Abe T; Tsukanishi T; Nakanishi K; Watanabe K; Hikata T; Suzuki S; Isogai N; Okada E; Funao H; Ueda S; Shiono Y; Nojiri K; Hosogane N; Ishii K
BMC Musculoskelet Disord; 2020 Jul; 21(1):420. PubMed ID: 32611386
[TBL] [Abstract][Full Text] [Related]
3. Re-fracture and correlated risk factors in patients with osteoporotic vertebral fractures.
Ma X; Xia H; Wang J; Zhu X; Huang F; Lu L; He L
J Bone Miner Metab; 2019 Jul; 37(4):722-728. PubMed ID: 30465091
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting postoperative mortality of patients with insufficient union following osteoporotic vertebral fractures and impact of preoperative serum albumin on mortality.
Ohba T; Yokomichi H; Koyama K; Tanaka N; Oda K; Haro H
BMC Musculoskelet Disord; 2020 Aug; 21(1):528. PubMed ID: 32778080
[TBL] [Abstract][Full Text] [Related]
5. Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study.
Fu SH; Wang CY; Hung CC; Lee CC; Yang RS; Huang CC; Farn CJ; Lin WH; Chen HM; Hsiao FY; Lin JW; Li CY
J Intern Med; 2021 Dec; 290(6):1194-1205. PubMed ID: 34237171
[TBL] [Abstract][Full Text] [Related]
6. Spinal pseudoarthrosis following osteoporotic vertebral fracture: prevalence, risk factors, and influence on patients' activities of daily living 1 year after injury.
Wakao N; Sakai Y; Watanabe T; Osada N; Sugiura T; Iida H; Ozawa Y; Murotani K
Arch Osteoporos; 2023 Mar; 18(1):45. PubMed ID: 36991181
[TBL] [Abstract][Full Text] [Related]
7. Is Bone Nonunion, Vertebral Deformity, or Spinopelvic Malalignment the Best Therapeutic Target for Amelioration of Low Back Pain After Osteoporotic Vertebral Fracture?
Iwata A; Kanayama M; Oha F; Shimamura Y; Hashimoto T; Takahata M; Iwasaki N
Spine (Phila Pa 1976); 2020 Jul; 45(13):E760-E767. PubMed ID: 32049935
[TBL] [Abstract][Full Text] [Related]
8. Elevated red blood cell distribution width is associated with poor outcome in osteoporotic vertebral fracture.
Sakai Y; Wakao N; Matsui H; Watanabe T; Iida H; Katsumi A
J Bone Miner Metab; 2021 Nov; 39(6):1048-1057. PubMed ID: 34196844
[TBL] [Abstract][Full Text] [Related]
9. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
[TBL] [Abstract][Full Text] [Related]
10. Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study.
Bliuc D; Tran T; van Geel T; Adachi JD; Berger C; van den Bergh J; Eisman JA; Geusens P; Goltzman D; Hanley DA; Josse RG; Kaiser S; Kovacs CS; Langsetmo L; Prior JC; Nguyen TV; Center JR;
Osteoporos Int; 2019 Apr; 30(4):817-828. PubMed ID: 30607457
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia and sarcopenic leg as potential risk factors for acute osteoporotic vertebral fracture among older women.
Hida T; Shimokata H; Sakai Y; Ito S; Matsui Y; Takemura M; Kasai T; Ishiguro N; Harada A
Eur Spine J; 2016 Nov; 25(11):3424-3431. PubMed ID: 25690348
[TBL] [Abstract][Full Text] [Related]
12. Impact of paravertebral muscle in thoracolumbar and lower lumbar regions on outcomes following osteoporotic vertebral fracture: a multicenter cohort study.
Habibi H; Takahashi S; Hoshino M; Takayama K; Sasaoka R; Tsujio T; Yasuda H; Kanematsu F; Kono H; Toyoda H; Ohyama S; Hori Y; Nakamura H
Arch Osteoporos; 2021 Jan; 16(1):2. PubMed ID: 33389230
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous Incidence of Vertebral Body Infection Following Osteoporotic Vertebral Fracture: A Case Series Study and Review of Literature.
Uto T; Tokuumi Y; Komine N; Yonezawa N; Demura S; Tsuchiya H
Spine (Phila Pa 1976); 2020 Jun; 45(12):E684-E687. PubMed ID: 31977675
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the quality of life in the chronic phase of thoracolumbar osteoporotic vertebral fracture managed conservatively with a brace.
Inose H; Kato T; Ichimura S; Nakamura H; Hoshino M; Takahashi S; Togawa D; Hirano T; Tokuhashi Y; Ohba T; Haro H; Tsuji T; Sato K; Sasao Y; Takahata M; Otani K; Momoshima S; Hirai T; Yoshii T; Takahashi K; Okawa A
Spine J; 2023 Mar; 23(3):425-432. PubMed ID: 36400395
[TBL] [Abstract][Full Text] [Related]
15. Vertebral mobility is a valuable indicator for predicting and determining bone union in osteoporotic vertebral fractures: a conventional observation study.
Sato K; Yamada Y; Kogawa M; Sekiguchi T
J Orthop Surg Res; 2020 May; 15(1):166. PubMed ID: 32370793
[TBL] [Abstract][Full Text] [Related]
16. Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter.
Tai TW; Tsai YL; Shih CA; Li CC; Chang YF; Huang CF; Cheng TT; Hwang JS; Lu TH; Wu CH
J Formos Med Assoc; 2023; 122 Suppl 1():S65-S73. PubMed ID: 37120337
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of the poor long-term prognosis of osteoporotic vertebral fractures: A multicenter cohort study.
Takahashi S; Terai H; Hoshino M; Tsujio T; Suzuki A; Namikawa T; Kato M; Matsumura A; Takayama K; Toyoda H; Tamai K; Ohyama S; Hori Y; Yabu A; Nakamura H
J Orthop Surg (Hong Kong); 2021; 29(1):2309499021994969. PubMed ID: 33626975
[TBL] [Abstract][Full Text] [Related]
18. Can anti-osteoporotic therapy reduce adjacent fracture in magnetic resonance imaging-proven acute osteoporotic vertebral fractures?
Chen YC; Lin WC
BMC Musculoskelet Disord; 2016 Apr; 17():151. PubMed ID: 27052323
[TBL] [Abstract][Full Text] [Related]
19. Effect of teriparatide (rh-PTH 1-34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study.
Iwata A; Kanayama M; Oha F; Hashimoto T; Iwasaki N
BMC Musculoskelet Disord; 2017 Apr; 18(1):148. PubMed ID: 28388910
[TBL] [Abstract][Full Text] [Related]
20. The variability of vertebral body volume and pain associated with osteoporotic vertebral fractures: conservative treatment versus percutaneous transpedicular vertebroplasty.
Andrei D; Popa I; Brad S; Iancu A; Oprea M; Vasilian C; Poenaru DV
Int Orthop; 2017 May; 41(5):963-968. PubMed ID: 28161853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
